Keratin 5 Polyclonal Antibody, Purified

Pricing & Availability
Clone
Poly19055 (See other available formats)
Isotype
Rabbit Polyclonal
Purified_Keratin-5_Antibody_IHC_021715
Anti-K5 antibody (clone Poly19055) showing strong cytoplasmic staining of the basal cells of normal human skin epidermis.
  • Purified_Keratin-5_Antibody_IHC_021715
    Anti-K5 antibody (clone Poly19055) showing strong cytoplasmic staining of the basal cells of normal human skin epidermis.
Cat # Size Price Quantity Avail. Save
905501 100 µL 299,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

This antibody is effective in immunohistochemistry (IHC).

Product Details
Instructions for Use (pdf)

Product Details

Product Information

Intended Use:

In Vitro Diagnostic (IVD). Use in immunohistochemistry (IHC) test methods only.

The polyclonal antibody Poly19055 is used for the in vitro examination of human biological samples using immunohistochemistry (IHC) methods for the qualitative identification of Keratin 5. The clinical interpretation of any staining or its absence should be complemented by morphological studies and proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.

Reactivity
Human
Immunogen
This monospecific polyclonal antibody was raised against a peptide sequence derived from the C-terminus of the mouse keratin 5 protein.
Formulation
Phosphate-buffered solution + 0.03% Thimerosal.
Preparation
The antibody was purified by peptide affinity chromatography.
Concentration
1.0 mg/mL
Storage & Handling
When stored at ≤ -20°C, product is stable until the date shown on the label. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody. If thawed and stored at 2-8°C, product is stable for 24 months from the date of thaw or until the expiry date on the label, whichever comes first.
Recommended Usage

Each lot of this antibody is quality control tested by immunohistochemical staining.

The optimal working dilution should be determined for each specific assay condition.
IHC: 1:2,000-4,000 with either biotin based detection systems such as USA Ultra Streptavidin Detection (Cat. No. 929501).

Tissue Sections: Paraffin-embedded tissues, frozen tissues
Pretreatment: For optimal staining, the sections should be pretreated with an antigen unmasking solution such as Citrate Buffer Retrieval solution (Cat. No. 928502).
Incubation: 60 minutes at room temperature

Application References

(PubMed link indicates BioLegend citation)
  1. Hübner A, et al. JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. PNAS, 109: 12046-12051, Jul 2012. [IHC] PubMed
  2. Kierszenbaum AL, Rivkin E, Tres LL. Acroplaxome, an F-actin-keratin-containing plate, anchors the acrosome to the nucleus during shaping of the spermatid head. Mol Biol Cell 14(11):4628-40, 2003. [IHC] PubMed
  3. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410:710-714, 2001.
  4. Yuspa SH, Kilkenny AD, Steinert PM, Roop DR. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in-vitro. J Cell Biol 109:1207-1217, 1989.
  5. Roop DR, Cheng CK, Titterington L, Meyers CA, Stanley JR, Steinert PM, Yuspa SH. Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem 259:8037-8040, 1984.
  6. Liang Y, 2011 Patholog Res Int. 2011:936794. (IHC) PubMed
  7. Easter SL, et al. 2014. PLoS One. 9:113247. (IF, WB) PubMed
  8. Osmanagic-Myers S, et al.2006. J Cell Biol. 174:557. (WB) PubMed
  9. Kittrell FS, et al. 2011. Breast Cancer Res.13:41. (IF) PubMed
  10. Croyle MJ, et al. Role of epidermal primary cilia in the homeostasis of skin and hair follicles. Development, 138: 1675-1685, May 2011. [IHC, IF] PubMed
  11. Bayo P, Sanchis A, Bravo A, Cascallana JL, Buder K, Tuckermann J, Schütz G, and PTrez P. Glucocorticoid Receptor Is Required for Skin Barrier Competence. Endocrinology, 149: 1377-1388, Mar 2008. [IHC] PubMed
Product Citations
  1. Bohnenpoll T, et al. 2017. PLoS Genet.. 10.1371/journal.pgen.1006951. PubMed
  2. Williams M, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0893-7. PubMed
  3. Li Q, et al. 2018. Neoplasia. 20:233. PubMed
  4. Nomeda Girnius et al. 2018. Cell death and differentiation. 25(9):1702-1715 . PubMed
  5. Nomeda Girnius et al. 2018. eLife. 7 pii: e36389. PubMed
  6. Weng PL et al. 2018. Cell reports. 24(6):1464-1470 . PubMed
  7. Ying Yang et al. 2018. Developmental cell. 44(6):752-761 . PubMed
  8. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  9. Lu Y, et al. 2018. Stem Cells. 36:1875. PubMed
  10. Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed
  11. Barros-Silva JD, et al. 2018. Cell Rep. 25:3504. PubMed
  12. Dumm RE, et al. 2019. Nat Commun. 10:779. PubMed
  13. Price AJ, et al. 2018. Nat Commun. 9:5284. PubMed
  14. Richards Z, et al. 2019. iScience. 12:304. PubMed
  15. Lee DH, et al. 2019. PLoS One. 14:e0211153. PubMed
  16. Jiao X, et al. 2019. Stem Cell Reports. 12:135. PubMed
  17. Huang M, et al. 2018. J Cell Sci. 131:. PubMed
  18. London NR, et al. 2019. Int Forum Allergy Rhinol. 9:114. PubMed
  19. Wang J, et al. 2018. Cell Rep. 25:464. PubMed
  20. Kullmann FA, et al. 2017. Am J Physiol Renal Physiol. 313:F85. PubMed
  21. Mamo TM, et al. 2017. Hum Mol Genet. 26:3553. PubMed
  22. Sreekumar A et al. 2017. Dev Cell. 43(4):436-448 . PubMed
  23. Shea MP, et al. 2018. Cancer Res. 78:1672. PubMed
  24. He Y, et al. 2018. Stem Cells. 36:891. PubMed
  25. Li Q, et al. 2018. J Biol Chem. 293:6434. PubMed
  26. Tripurani SK, et al. 2018. Mol Biol Cell. 29:2784. PubMed
  27. Hollern DP, et al. 2019. Breast Cancer Res Treat. 174:143. PubMed
  28. Xiong X et al. 2018. Cell reports. 25(11):3006-3020 . PubMed
  29. Sépult C, et al. 2019. Oncogene. 38:3521. PubMed
  30. Kwon OJ, et al. 2019. iScience. 13:328. PubMed
  31. Lecland N, et al. 2019. Life Sci Alliance. 2:2. PubMed
  32. Fang X, et al. 2019. Am J Pathol. 189:1212. PubMed
  33. Smith P, et al. 2019. Sci Rep. 9:7079. PubMed
  34. Ramovs V, et al. 2019. Breast Cancer Res. 21:63. PubMed
  35. Bresson L, et al. 2018. Development. 145. PubMed
  36. Norum JH, et al. 2019. Int J Cancer. web only. PubMed
  37. Dong B, et al. 2018. Development. 145. PubMed
  38. Li Q, et al. 2018. J Biol Chem. 293:10547. PubMed
  39. Ackermann T, et al. 2019. Commun Biol. 2:208. PubMed
  40. Berger A, et al. 2019. J Clin Invest. 130:3924. PubMed
  41. Miao Q, et al. 2019. Nat Commun. 10:4042. PubMed
  42. May AJ, et al. 2018. Development. 145. PubMed
  43. Pfefferle AD, et al. 2019. Dis Model Mech. 12:?dmm037192. PubMed
  44. Dedeić Z, et al. 2018. Cell Death Differ. 25:1289. PubMed
  45. Fougner C, et al. 2019. Breast Cancer Res. 21:85. PubMed
  46. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  47. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  48. Girnius N et al. 2017. Cell reports. 21(7):1910-1921 . PubMed
  49. Inoue SI, et al. 2017. Hum Mol Genet. 26:4715. PubMed
  50. Lazarus KA, et al. 2018. Nat Commun. 2.685416667. PubMed
  51. Yanagi T, et al. 2018. Cancer Res. 78:6795. PubMed
  52. Mi J, et al. 2018. J Biol Chem. 293:20123. PubMed
  53. Khatri A, et al. 2019. Oncotarget. 1.718055556. PubMed
  54. Vijayaraj P, et al. 2019. Cell Rep. 29:3488. PubMed
  55. Zhang B, et al. 2020. Nat Commun. 1.150694444. PubMed
  56. Aros CJ, et al. 2020. Cell Rep. 30:2055. PubMed
  57. Fujino N, et al. 2019. J Exp Med. 216:2184. PubMed
  58. Yuan Y, et al. 2020. Nat Commun. 11:1472. PubMed
  59. Sumbal J, et al. 2020. Front Cell Dev Biol. 8:68. PubMed
  60. Liu C, et al. 2019. Nat Commun. 10:4589. PubMed
  61. Jung HY, et al. 2019. Nat Cell Biol. 21:359. PubMed
  62. Cheng CY, et al. 2020. Oncogenesis. 9:38. PubMed
  63. Piao X, et al. 2019. J Allergy Clin Immunol. 143:213. PubMed
  64. Sfakianos JP, et al. 2020. Nat Commun. 2.222222222. PubMed
  65. Stupnikov MR, et al. 2020. eLife. 8:e50487.. PubMed
  66. Wu H, et al. 2020. Cell. 180(1):107-121.e17.. PubMed
  67. Joseph KB, et al. 2020. Chemical Senses. bjaa039.. PubMed
  68. Kierszenbaum A, et al. 2003. Mol Biol Cell. 14:4628-4640. PubMed
  69. Liang Y 2011. Patholog Res Int. 2011:936794. PubMed
  70. Bayo P, et al. 2008. Endocrinology. 149:1377-1388. PubMed
  71. Hübner A, et al. 2012. Proc Natl Acad Sci U S A. 109:12046-12051. PubMed
  72. Osmanagic-Myers S, et al. 2006. J Cell Biol. 174:557-568. PubMed
  73. Kittrell F, et al. 2011. Breast Cancer Res. 13:R41. PubMed
  74. Croyle M, et al. 2011. Development. 138:1675-1685. PubMed
  75. Easter S, et al. 2014. PLoS One. 9:e113247. PubMed
  76. Maimets M, et al. 2016. Stem Cell Reports. 6:150-162. PubMed
  77. Johnson D, et al. 2016. PLoS One. 11: 0148851. PubMed
  78. Triplett T, et al. 2016. Proc Natl Acad Sci U S A. 113: 1016 - 1025. PubMed
  79. Tadokoro T, et al. 2016. Development. 143: 764 - 773. PubMed
  80. Wang H, et al. 2016. PLoS One. 11: 0152641. PubMed
  81. Park J, et al. 2016. Proc Natl Acad Sci U S A. 113: 4482-4487. PubMed
  82. Balasooriya G, et al. 2016. Dev Cell. 37: 85-97. PubMed
  83. Linn D, et al. 2016. Cancer Res . 76: 1869-1881. PubMed
  84. Kwon O, et al. 2016. Stem Cell Res. 16: 682-691. PubMed
  85. Wang N, et al. 2016. Stem Cell Reports. 6: 668-678. PubMed
  86. Turpin J, et al. 2016. Oncogene. 10.1038/onc.2016.129. PubMed
  87. Papafotiou G, et al. 2016. Nat Commun. 7:11914. PubMed
  88. Wuidart A, et al. 2016. Genes Dev. 30: 1261 - 1277. PubMed
  89. Jullien D, et al. 2016. J Cell Sci. 129: 2673 - 2683. PubMed
  90. Akiyama N, et al. 2016. J Exp Med. 213: 1441 - 1458. PubMed
  91. Wang H, et al. 2016. J Immunol. 197: 141 - 150. PubMed
  92. Adriaens C, et al. 2016. Nat Med. 10.1038/nm.4135. PubMed
  93. Žuklys S, et al. 2016. Nat Immunol. 17:1206-1215. PubMed
  94. Liu S, et al. 2016. PLoS One. 11:e0163232. PubMed
  95. Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed
  96. Davis F, et al. 2016. Nat Commun. 7:13053. PubMed
  97. Bhagirath D, et al. 2016. PLoS One. 11:e0167064. PubMed
  98. Wu M, et al. 2016. J Biol Chem. 291(49):25749-25760. PubMed
  99. Bohnenpoll T, et al. 2016. J Am Soc Nephrol. 2016080849. PubMed
  100. Yang Z, et al. 2017. Dis Model Mech. 10(1):39-52. PubMed
  101. Song Y, et al. 2017. PLoS One. 12(2):e0171510. PubMed
  102. Tao L, et al. 2017. Nat Commun. 8:14431. PubMed
  103. Håglin S, et al. 2020. J Neurosci. 40:4116. PubMed
  104. Cayre S, et al. 2020. Development. 147:00:00. PubMed
  105. Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed
  106. Stevens ML, et al. 2020. Nat Commun. 3.3. PubMed
  107. Cheng S, et al. 2020. Prostate Cancer Prostatic Dis. 1.417361111. PubMed
  108. Yin Y, et al. 2020. Sci Signal. 13:00. PubMed
  109. McGinn O, et al. 2020. Oncogene. 39:2478. PubMed
  110. Tommasi C, et al. 2020. J Invest Dermatol. 140:774. PubMed
  111. Frumm SM, et al. 2020. Cell Stem Cell. 28(2):315-330.e5. PubMed
  112. Bannier-Hlaout M, et al. 2021. Cell Stem Cell. 28(7):1221-1232.e7. PubMed
  113. Busslinger GA, et al. 2021. Cell Reports. 34(10):108819. PubMed
  114. Biswas R, et al. 2021. Developmental Cell. 56(6):761-780.e7. PubMed
  115. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  116. Bentez S, et al. 2021. Developmental Cell. 56(12):1727-1741.e7. PubMed
  117. Chen D, et al. 2021. STAR Protocols. 2(2):100484. PubMed
RRID
AB_2565050 (BioLegend Cat. No. 905501)
Disclaimer

WARNINGS AND PRECAUTIONS

  1. Use appropriate personal protective equipment and safety practices per universal precautions when working with this reagent. Refer to the reagent safety data sheet.
  2. All specimens, samples and any material coming in contact with them should be considered potentially infectious and should be disposed of with proper precautions and in accordance with federal, state and local regulations.
  3. Do not use this reagent beyond the expiration date stated on the label.
  4. Do not use this reagent if it appears cloudy or if there is any change in the appearance of the reagent as these may be indication of possible deterioration.

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 06.29.2020

Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account